user
menu
letter
Sign InRegister
langEnglisharrow

HSV-1 (strain 17) Envelope Glycoprotein D (gD), His Tag (MALS verified)

Cat. No. / Size
Price
Availability
Qty
GLD-V52H3-50ug
$305.00
In Stock - Delivery in 1-2 business days
GLD-V52H3-500ug
$1,545.00
Inquire about delivery time
GLD-V52H3
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
Request Quote
Product Details
Performance Data
Reviews & Citations
Resources
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Synonyms

Glycoprotein D/gD (HSV)

Source

HSV-1 (strain 17) Envelope Glycoprotein D (gD), His Tag (GLD-V52H3) is expressed from human 293 cells (HEK293). It contains AA Lys 26 - Thr 310 (Accession # Q69091-1).

Predicted N-terminus: Lys 26

Molecular Characterization
Other Tags and Version Biotin & Other Labeled Version

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 33.5 kDa. The protein migrates as 40-50 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 1.0 EU per μg by the LAL method / rFC method.

Purity

>90% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Shipping and Storage

This product is shipped at ambient temperature.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System

Background

Herpes simplex virus type 1 (HSV‑1) glycoprotein D (gD) is an essential envelope protein required for viral entry. By binding host receptors such as nectin‑1, gD triggers the membrane‑fusion cascade that allows HSV‑1 to penetrate cells. Neutralizing antibodies targeting gD can block receptor engagement and inhibit infection.